Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Profit After Tax (2018 - 2025)

Historic Profit After Tax for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $25.8 million.

  • AdaptHealth's Profit After Tax rose 749.32% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.8 million, marking a year-over-year increase of 14043.06%. This contributed to the annual value of $94.8 million for FY2024, which is 11396.09% up from last year.
  • Latest data reveals that AdaptHealth reported Profit After Tax of $25.8 million as of Q3 2025, which was up 749.32% from $15.8 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Profit After Tax ranged from a high of $80.1 million in Q2 2021 and a low of -$454.1 million during Q3 2023
  • Moreover, its 5-year median value for Profit After Tax was $16.7 million (2023), whereas its average is -$16.7 million.
  • As far as peak fluctuations go, AdaptHealth's Profit After Tax soared by 116480.08% in 2022, and later plummeted by 1610006.37% in 2023.
  • AdaptHealth's Profit After Tax (Quarter) stood at $23.5 million in 2021, then plummeted by 106.69% to -$1.6 million in 2022, then crashed by 16100.06% to -$254.5 million in 2023, then surged by 120.2% to $51.4 million in 2024, then tumbled by 49.91% to $25.8 million in 2025.
  • Its Profit After Tax stands at $25.8 million for Q3 2025, versus $15.8 million for Q2 2025 and -$7.2 million for Q1 2025.